Klinger H, Chen K W, Stevens L M. "一种伊布替尼杂质87的合成方法" [P]. US Patent, US 9534085 B2, 2015-08-16.
发明人杨光,张德明,郑宇鹏. "Method for the Synthesis of Ibrutinib Impurity 87" [P]. 中国发明专利, 专利号 CN 114020786 B, 授权公告日 2015-05-10.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质87 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2012, 783, (5), 9698-9724.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质87 as an Impurity". J. Nat. Prod., 2022, 2384, 3539-3544.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 87 Using HRMS and NMR". Phytochemistry, 2020, 1015, (12), 4587-4600.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 伊布替尼杂质87 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2023, 504, (12), 1315-1326.